City
Epaper

Nureca Limited Reports 87% Growth for Q4 FY25, Expands Reach with Swiggy and Release Strategic Priorities for FY 26

By ANI | Updated: May 6, 2025 13:22 IST

NewsVoirMumbai (Maharashtra) [India], May 6: Nureca Limited, a leading player in the home healthcare and wellness industry, today ...

Open in App

NewsVoir

Mumbai (Maharashtra) [India], May 6: Nureca Limited, a leading player in the home healthcare and wellness industry, today announced its financial results for the fourth quarter and year ended March 31, 2025

Key Highlights:

Strong Financial Performance

* Q4 FY25 (Jan-Mar 2025)

* Revenue surged 87% to Rs. 31.74 crore (from Rs. 16.97 crore in Q4 FY24)

* EBIDTA improved 156% to Rs. 3.2 crore (from Rs. -5.6 crore in Q4 FY24)

* Full Year FY25

* Revenue grew 19.3% to Rs. 109.66 crore (from Rs. 91.9 crore in FY24)

* EBIDTA increased 1489% to Rs. 4.9 crore (from Rs. 0.3 crore in FY24)

Regulatory Milestone: USFDA Registration

Nureca Technologies Private Limited, the manufacturing arm of Nureca Limited, has successfully completed its annual registration with the U.S. FDA for its 510(k)-exempt medical devices. This milestone validates the company's regulatory compliance and strengthens its global export capabilities from its Mohali-based facility.

Channel Expansion: D2C & Quick Commerce

Nureca continues to scale its Direct-to-Consumer (D2C) channel, investing in website UX, digital marketing, influencer engagement, and customer service. The company also expanded its reach through Swiggy instamart, reinforcing its commitment to convenient, on-demand wellness solutions. Our products are already available on quick commerce platforms like Blinkit and Zepto, apart from all leading online marketplaces.

Key Strategic Priorities for FY26

* Manufacturing Expansion: Operationalize and scale production at the Punjab facility to support local and export markets.

* Quick Commerce Leadership: Deepen partnerships, expand product assortment, and optimize fulfillment models for quick commerce platforms.

* Innovation Pipeline: Launch new health, wellness, and fitness SKUs aligned to emerging consumer needs.

* Export Growth: Leverage US FDA certifications to expand into North American and Middle Eastern markets.

I would like to take this opportunity to express my gratitude to our shareholders for their continued confidence in Nureca. We are excited about the opportunities that lie ahead and are committed to delivering strong results in the coming quarters

(ADVERTORIAL DISCLAIMER: The above press release has been provided by NewsVoir.will not be responsible in any way for the content of the same)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Other SportsIPL 2025: Suryakumar Yadav moves to second in players with most consecutive 25+ scores in T20s

NationalMP: Congress leader alleges irregularities persistent in Regional Transport Office

CricketIPL 2025: Jacks, Corbin shine as MI powers to 155 in their 20 overs against GT

NationalUttar Pradesh: Yogi govt pushes 'Digital India Vision' with land records overhaul

Other SportsGary Ballance joins Zimbabwe coaching staff for England tour

Business Realted Stories

BusinessNSE clocks total income of Rs 4,397 crore in Q4, recommends Rs 35 dividend

BusinessIndia Inc welcomes UK trade pact, highlights positives of FTA

BusinessEU not to be pressured into unfair US tariff deal, says trade chief

BusinessBSE reports 364 pc jump in profits, announces Rs 23 dividend per share

BusinessPM Modi invites UK PM Starmer to visit India amid strong economic ties